Can denatured protein samples containing urea and reducing agents be processed with an endotoxin removal kit?

Detection and budgeting must be considered together. Both 6 M urea and DTT interfere with LAL; before testing, dilute to the compatibility range specified by the reagent manufacturer, or use recombinant Factor C/interference-resistant Limulus amebocyte lysate, and perform endotoxin spike recovery. Before and after processing, in addition to LAL, also run SDS-PAGE to check for low-molecular-weight impurity bands and determine whether ligand shedding has occurred; measure A280 to check for abnormal absorbance in the flowthrough. For budgeting, do not only ask about the unit price of the resin; include prepacked columns/bulk resin, pyrogen-free buffers, filters, and endotoxin detection reagents. The per-run cost of self-packing a 10 mL denatured sample column is usually manageable, but if validation is insufficient, losing a batch of protein is actually more expensive.

Domestic stability needs to be evaluated separately: for domestic manufacturers making chromatography resins, such as Bio-Gel and Huiyan, anion exchange resins themselves are usually not a major issue in terms of tolerance to urea and reducing agents, and stability data can be requested from sales. Regarding pricing, I do not dare quote specific numbers on their behalf, but if you pack your own column with bulk resin, the consumable cost per single run for a 10 mL sample is usually lower than that of imported prepacked columns; however, you need to perform your own depyrogenation and validation. Imported options such as Cytiva Capto Q or similar strong anion exchange resins can also be used for endotoxin removal, but they are general-purpose resins, not dedicated endotoxin removal kits, with limited documentation support, so you need to establish the conditions yourself. Overall, if a domestic product has a clearly documented model and cases supporting tolerance to 6M urea/DTT, you can first try a small package.

In operation, clogging is the biggest concern. 6 M urea has high viscosity, and the spin column may flow very slowly even at low speed. It is recommended to use a gravity column or a syringe for slow manual pushing, not high-speed centrifugation. Before processing, take 1 mL for a preliminary experiment to confirm flow rate, endotoxin removal, and protein recovery. If the column bed becomes clogged, you can try centrifuging the sample or passing it through a 0.45 μm pyrogen-free filter, but the filter may also adsorb denatured proteins and must be validated. If only a small amount of DTT is present, oxidation after processing will affect the protein; consider promptly supplementing reducing agent in the flow-through; however, do not add excessively high concentrations of DTT before the column, so as not to affect the stability of the medium.

Samples containing 6 M urea plus DTT are indeed unusual, and affinity-type endotoxin removal columns (polymyxin B, histamine ligands) are not necessarily tolerant to them, with a relatively high risk of ligand leaching. I recommend prioritizing strong anion exchange-type or dedicated endotoxin removal ion exchange resins, which rely on charge binding to LPS and are generally more stable in urea and low-concentration reducing agents. Be sure to request tolerance data from the manufacturer, and explicitly ask about ligand leaching, flow rate, and binding capacity changes after soaking or continuous use for 24 h in 6 M urea and 5 mM DTT. If clear data are not available, it is best to perform a small-volume test first. Your 10 mL, 2 mg/mL sample may expose hydrophobic regions when the protein unfolds under denaturing conditions, so nonspecific adsorption should also be noted.